MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 55 filers reported holding MYOVANT SCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,809,232 | +53.8% | 104,200 | +2.5% | 0.00% | +100.0% |
Q3 2022 | $1,827,000 | +47.6% | 101,700 | +2.1% | 0.00% | 0.0% |
Q2 2022 | $1,238,000 | +5.4% | 99,600 | +12.9% | 0.00% | 0.0% |
Q1 2022 | $1,175,000 | -6.7% | 88,200 | +9.0% | 0.00% | 0.0% |
Q4 2021 | $1,260,000 | -30.6% | 80,900 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,815,000 | -0.5% | 80,900 | +1.0% | 0.00% | 0.0% |
Q2 2021 | $1,824,000 | +7.0% | 80,100 | -3.3% | 0.00% | 0.0% |
Q1 2021 | $1,704,000 | -24.3% | 82,800 | +1.6% | 0.00% | -50.0% |
Q4 2020 | $2,251,000 | +96.6% | 81,500 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $1,145,000 | -30.8% | 81,500 | +1.6% | 0.00% | 0.0% |
Q2 2020 | $1,654,000 | +180.3% | 80,200 | +2.6% | 0.00% | 0.0% |
Q1 2020 | $590,000 | -50.7% | 78,200 | +1.4% | 0.00% | 0.0% |
Q4 2019 | $1,197,000 | +215.0% | 77,100 | +5.6% | 0.00% | – |
Q3 2019 | $380,000 | -42.5% | 73,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $661,000 | -11.3% | 73,000 | +134.0% | 0.00% | 0.0% |
Q1 2019 | $745,000 | +50.2% | 31,200 | +3.3% | 0.00% | 0.0% |
Q4 2018 | $496,000 | -34.0% | 30,200 | +6.7% | 0.00% | 0.0% |
Q3 2018 | $751,000 | +16.1% | 28,300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $647,000 | +7.5% | 28,300 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $602,000 | +89.9% | 28,300 | +12.7% | 0.00% | – |
Q4 2017 | $317,000 | -18.3% | 25,100 | 0.0% | 0.00% | – |
Q3 2017 | $388,000 | +32.0% | 25,100 | 0.0% | 0.00% | – |
Q2 2017 | $294,000 | – | 25,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |
VitalStone Financial, LLC | 15 | $0 | 0.00% |